Document is current
Any future updates will be listed below
-
Authors
Monteiro, Vaneisse C. L.
de Oliveira, Bibiana M.
dos Santos, Bruna B.
Sperb-Ludwig, Fernanda
Refosco, Lilia F.
Nalin, Tatiele
Derks, Terry G. J.
Moura de Souza, Carolina F.
Schwartz, Ida V. D. https://orcid.org/0000-0002-7933-6687
-
Funding
Funding for this research was provided by:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Hospital de Clínicas de Porto Alegre
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
- License Information
-
More Information
Article History
Received: 10 February 2021
Accepted: 21 May 2021
First Online: 3 June 2021
Declarations
:
: This study was approved by the HCPA Research Ethics Committee (protocol #52645116500005327) and ClinicalTrials.gov (NCT03871673). All participants or their legal guardians signed an informed consent form.
: “Not applicable”.
: TN is currently an employee of Ultragenyx Farmacêutica Brasil LTDA and hold stock in Ultragenyx Pharmaceutical Inc. All other authors declare no conflicts of interest.
